A sustained-release theophylline preparation in capsule form was compared with standard slow-release theophylline tablets for variation in plasma theophylline concentration, effectiveness and tolerability in 30 adults with chronic broncho-obstructive pathology. They were administered every 12 h and blood samples were collected after 8 days of treatment during the steady-state period. In this double-dummy crossover study, the sequence of the two regimens (sustained-release capsules versus tablets) was selected at random. The results of this study demonstrate that plasma theophylline levels remain within the therapeutic range for both preparations. Effectiveness and tolerability of the two drugs were satisfactory.
Get full access to this article
View all access options for this article.
References
1.
Webb-JohnsonDCAndrewsJLJr: Bronchodilator therapy. N Engl J Med1977; 297: 758–764.
2.
FishmanAP: State of the art–chronic cor pulmonale. Am Rev Respir Dis1976; 114: 775–794.
3.
AlexanderMRDullWLKasikJE: Treatment of chronic obstructive pulmonary disease with orally biadministered theophylline. J Am Med Assoc1980; 244: 2286–2290.
4.
CampoSChiappiniMGCollocaA: Sustained release theophylline administration versus continuous theophylline infusion in old patients with acute respiratory failure. Eur J Respir Dis1980; 64 (suppl 126): 538–539
5.
OgilvieRJ: Clinical pharmacokinetics of theophylline. Clin Pharmacokinet1978; 3: 267–293.
6.
SalterH: On some points in the treatment and clinical history of asthma. Edimb Med J1859; 1109–1115
7.
HerrmanGAynesworthMBMartinJ: Successful treatment of persistent dyspnea status asthmaticus. J Lab Clin Med1937; 23: 135–148.
8.
JenneJWWyzeERossFS: Pharmacokinetics of theophylline, application to and adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther1972; 13: 349–360.
9.
HendelesLWeibergerMBighleyL: Disposition of theophylline after a single intravenous infusion of aminophylline. Annu Rev Respir Dis1978; 118: 97–103.
10.
SoldinSJAinJG: A rapid micromethod for measuring theophylline in serum by reverse-phase high performance liquid chromatography. Clin Biochem1977; 10: 74–77.
11.
IshizakiTWatanabeMMorisaitaM: The effect of assay method on plasma levels and pharmacokinetics of theophylline: HPLC and EIA. Br J Clin Pharmacol1979; 7: 333–341.
GoodsellEBSteinHHWenzkeKJ: 8-Substituted theophyllines. In vitro inhibition of 3‘, 5’-cyclic adenosine monophosphate phosphodiesterase and pharmacological spectrum in mice. J Med Chem1971; 14: 1202–1205.
14.
BaxterJH: Histamine release from rat mastcells by dextran: effects of adrenergic agents, theophylline, and other drugs. Proc Soc Exp Biol Med1972; 141: 576–581.
15.
MarquardtDLParkerCWSullivansTJ: Potentiation of mastcell mediator release by adenosine. J Immunol1978; 120: 871–878.
16.
JacobsMHSeniorRMKesslerG: Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity. J Am Med Assoc1976; 235: 1983–1986.
17.
YannellPRChuNS: Focal seizures and aminophylline. Neurology (Minneap)1975; 25: 819–822.
18.
MitenkoPAOgilvieRJ: Rational intravenous dose of theophylline. N Engl J Med1973; 289: 600–603.
CharpinJ: Les taux plasmatiques de theophylline condamnent ils les formes enterales?Nouv Presse Med1978; 7: 2656.
21.
RuffF: Interet des dosages de la theophyllinemie. Nouv Presse Med1978; 7: 1750–1751.
22.
AndersenO: Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations. J Pharm Sci1983; 72: 158–165.
23.
WoodcockAA: Theophylline prescribing, serum concentration, and toxicity. Lancet1983; ii: 610–612.
24.
LeungPKaliskerABellTD: Variation in theophylline clearance rate with time in chronic childhood asthma. J Allergy Clin Immunol1977; 59: 440–444.
25.
WoodJHGarrettsonLK: The explanation of circadian rhythm for theophylline and other drugs. Lancet1983; ii: 570.
26.
WeibergerHHendelesLBighleyL: The relation of product formulation to absorption of oral theophylline. N Engl J Med1978; 299: 852–857.
27.
MeyerCMStranghnABLierbermanP: A multiple-dose study of sustained release theophylline and aminophylline, Chest1978; 78: 300–303.
28.
TinkelmanD: Theophylline: the concept of sustained action. J Asthma1981; 18: 35–37.
29.
MarchioniCFPenitentiSBernocchiD: Confronto tra i livelli plasmatici di Teonova liquido e di una preparazione galenica di Teofillina elisir. Biol Med (Paris)1987; 9: 61–66.
30.
TinkelmanD: Theophylline: the concept of sustained action. J Asthma1981; 18: 35–37.
31.
TinkelmanDGWanderpoolGECarrolMS: Compliance differences following administration of theophylline at six and twelve hour intervals. Ann Allergy1980; 44: 283–286.
32.
WoodPRCaseyRKolsyGB: Compliance with oral theophylline therapy in asthmatic children. Ann Allergy1985; 54: 400–401.
33.
CorsicoRMerigiA: The activity and tolerability of a new once-daily theophylline preparation. Clin Trials J1986; 23: 359–371.
34.
MarchioniCFMattioliGPenitentiS: Towards a renewal of the theophylline therapy in the broncho-obstructive chronic pathology. Ital J Chest Dis1987; 41: 48–55.
